
Celebrating awardee @kirkcampbell at the Mount Sinai Jacobi Medallion Award Ceremony at the Plaza Hotel in NYC 🏆 🏆🏆 @DOMSinaiNYC @ISMMSKidney
✓Nephrologist @PennKidney | Interested in Vascular Access & Onconephrology | Tweets are not medical advice | Opinions my own

Celebrating awardee @kirkcampbell at the Mount Sinai Jacobi Medallion Award Ceremony at the Plaza Hotel in NYC 🏆 🏆🏆 @DOMSinaiNYC @ISMMSKidney

Another Kidney Week comes to a close! A wonderful few days of learning, and reconnecting with friends. Until next year! #KidneyWk

It’s not Kidney christmas without @Tiff_Caza ! And a surprise sighting of @kirkcampbell and @aishaikh to round out the day. #KidneyWk

Thank you so much, @ShrutiGkidney and @rc_oncneph for putting together such a wonderful symposium. I truly enjoyed being part of it and learned so much from the fantastic speakers and discussions. It was also especially nice to spend time with everyone and catch up. And Jeopardy may have brought out everyone’s competitive side but that made it more fun 😄

If you work in onconephrology, Dr Nelson Leung is one of those names you keep coming back to. Mayo nephrologist + hematologist, and founder/president of the International Kidney & Monoclonal Gammopathy Research Group. @rc_oncneph @MayoClinicNeph

A useful OncoNephrology session by Aisha Shaikh @aishaikh on a deceptively simple question: What’s the GFR? Kidney function matters throughout cancer care, from trial eligibility and drug dosing to recognising nephrotoxicity. @rc_oncneph @ShrutiGkidney

Nephrocentric vs Nephrotolerant: When is it Safe to Rechallenge? @BetterCallSeeth @aishaikh @AstridWeins, A patient with cancer develops rapidly increasing proteinuria, but creatinine remains stable. The case presented today showed why the kidney biopsy can still matter.

When Onconephrologists play Jeopardy… things get seriously competitive. 😂🧠 Onconephrology, but make it fun-er. 🔥 @rc_oncneph @ShrutiGkidney @kdjhaveri @MGBKidneys @rimdawan @aishaikh @JayaKala11 Kidneys don’t lie 🥊Vs 🥊Malignant Kidneys !!

Day 1 in the books. 📸 with Faculty and Gupta lab! @ShrutiGkidney Thank you all for a successful day 1! @OncnephBoston26 @onconephsociety @DanaFarber @BrighamWomens @harvardmed

🚨 Big news! 🚨 The Onconephrology Symposium 2026 is now endorsed by the International Society of Nephrology (ISN)! 🌎🩺 @ISNkidneycare @ISNeducation 📍 Boston, MA | 📅 Sept 17–18 ⏳ We’re almost at full capacity, Registration closes soon!! Don’t miss it!!✨ @rc_oncneph

🎉 Come for the science, and stay for Boston! 🗓️Sep 17-18, 2026 Join us for: 🎊The ASON reception 🥂Cocktail Hour 🏫Campus tour of Brigham, Dana-Farber & Harvard Medical School with a group photo. Register ASAP → learn.hms.harvard.edu/progra… @rc_oncneph @ShrutiGkidney

Kidney Transplantation Post–Chimeric Antigen Receptor (CAR) T-Cell Therapy in Multiple Myeloma bit.ly/4x9z3wY (OPEN ACCESS) @D_M_Dadhania @aishaikh

💥 In this case report we describe the feasibility and challenges of kidney transplantation after CAR T-cell therapy in Multiple Myeloma @AJKDonline ajkd.org/article/S0272-6386(… @D_M_Dadhania @LandauHeather

The Loma Linda Nephrology Webinar Series is hosting an Onconephrology webinar on July 17, 2026. Join us for an opportunity to learn directly from leading experts in the field! 🔗 Free Registration: eeds.com/live/594229 @onconephsociety

Excited to share our review in @NatRevUrol “Urolithiasis in Patients with Cancer” @arihakimi We discuss unique mechanisms driving stone disease in cancer patients, bidirectional relationship between cancer & urolithiasis, management of urolithiasis in this pt population pubmed.ncbi.nlm.nih.gov/4233…

Final picture! We would like to thank all the Speakers and Moderators and everyone who attended in person and livestream ! Safe travels back home . @rc_oncneph @LeticiaRolonMD @onconeph @AbdullahJalalMD @MayoClinicNeph @onconephsociety